Amgen has agreed to acquire the global rights to Otezla, a drug used for the treatment of psoriasis and psoriatic arthritis, for $13.4 billion in cash, Bristol Myers Squibb said Monday.
Aug 26, 2019
0
2
The European Commission on Wednesday authorised a merger of US drug giant Pfizer's off-patent business unit with the pharmaceutical company Mylan to create a global powerhouse for lower-cost medicines.
Apr 22, 2020
0
4
The pharmaceuticals sector is facing an intensive period of mergers and acquisitions in the coming years, even if US firms Pfizer and Allergan recently failed to tie the knot, the corporate consultancy firm EY said Monday.
May 30, 2016
0
3
The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
(HealthDay)—Vertical level mergers, which incorporate not just health care providers, but also insurers, retailers, and pharmacy benefit managers (PBMs), could pose challenges in primary care, according to an article published ...
Jun 25, 2018
0
0
Our nation's rural hospitals are struggling. Between 2010 and 2021, almost 140 rural hospitals closed. Additionally, about one-third of the rural hospitals still operating are unprofitable. Rural hospitals struggle financially ...
Jun 16, 2023
0
3
Around the world, ventilators—a life-saving medical device that keeps air flowing into the lungs of a patient who is unable to breathe—are a scarce resource in hospitals and clinics where they're used to treat those infected ...
Apr 27, 2020
0
1
Hospital and health system mergers set a record in 2017, with a new report saying networks of care providers bulked up to offer a broader range of services and prepare for new contracts that ask health systems to take financial ...
Jan 31, 2018
0
4
Competition from generic drugs continued to hammer French pharmaceutical group Sanofi in the second quarter, the company said Thursday, warning that its full-year earnings could be twice as bad as previous guidance.
Aug 1, 2013
0
0
In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and low interest rates ...
Nov 23, 2014
0
0
